Commercialisation is at full-pace for Orthocell (ASX:OCC) in the US$1.6 billion nerve repair market, as the company pushes ahead with the rollout of ...

While the S&P/ASX 200 notched a strong performance on Tuesday, rising 36 points or 0.41%, the Small Ordinaries index dipped 0 ...

Australian shares are on track for a modest rise at the open, with ASX 200 futures up 14 points (+0.15%) at 8:30 am AEST. The ...

The ASX200 closed around .4 of a per cent up - utilities and consumer discretionary topped today's gains - whilst industrials ...